Charles Schwab’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $72.1M | Buy |
1,313,103
+18,048
| +1% | +$739K | 0.01% | 990 |
|
|
2026
Q1 | $43M | Sell |
1,295,055
-16,634
| -1% | -$496K | 0.01% | 1259 |
|
|
2025
Q4 | $39.1M | Buy |
1,311,689
+1,532
| +0.1% | +$50K | 0.01% | 1311 |
|
|
2025
Q3 | $47.3M | Sell |
1,310,157
-6,339
| -0.5% | -$209K | 0.01% | 1194 |
|
|
2025
Q2 | $47.4M | Buy |
1,316,496
+53,559
| +4% | +$1.99M | 0.01% | 1142 |
|
|
2025
Q1 | $49.8M | Sell |
1,262,937
-6,576
| -0.5% | -$221K | 0.01% | 1074 |
|
|
2024
Q4 | $38.2M | Buy |
1,269,513
+84,904
| +7% | +$2.44M | 0.01% | 1320 |
|
|
2024
Q3 | $27.7M | Buy |
1,184,609
+7,939
| +0.7% | +$173K | 0.01% | 1515 |
|
|
2024
Q2 | $20.9M | Buy |
1,176,670
+31,101
| +3% | +$496K | ﹤0.01% | 1655 |
|
|
2024
Q1 | $17.4M | Buy |
1,145,569
+13,673
| +1% | +$218K | ﹤0.01% | 1697 |
|
|
2023
Q4 | $19.3M | Buy |
1,131,896
+19,214
| +2% | +$223K | ﹤0.01% | 1617 |
|
|
2023
Q3 | $9.3M | Buy |
1,112,682
+31,872
| +3% | +$444K | ﹤0.01% | 1947 |
|
|
2023
Q2 | $26.8M | Buy |
1,080,810
+35,058
| +3% | +$906K | 0.01% | 1282 |
|
|
2023
Q1 | $15.7M | Buy |
1,045,752
+27,445
| +3% | +$417K | ﹤0.01% | 1636 |
|
|
2022
Q4 | $12M | Buy |
1,018,307
+27,449
| +3% | +$199K | ﹤0.01% | 1756 |
|
|
2022
Q3 | $5.87M | Buy |
990,858
+49,186
| +5% | +$323K | ﹤0.01% | 2129 |
|
|
2022
Q2 | $4M | Sell |
941,672
-13,751
| -1% | -$85.9K | ﹤0.01% | 2287 |
|
|
2022
Q1 | $9.09M | Buy |
955,423
+17,029
| +2% | +$197K | ﹤0.01% | 2009 |
|
|
2021
Q4 | $17.8M | Buy |
938,394
+23,927
| +3% | +$621K | 0.01% | 1671 |
|
|
2021
Q3 | $30.4M | Buy |
914,467
+45,885
| +5% | +$1.42M | 0.01% | 1215 |
|
|
2021
Q2 | $33.7M | Buy |
868,582
+27,619
| +3% | +$1.08M | 0.01% | 1160 |
|
|
2021
Q1 | $40.5M | Buy |
840,963
+113,794
| +16% | +$5.47M | 0.01% | 973 |
|
|
2020
Q4 | $37.8M | Buy |
727,169
+34,116
| +5% | +$1.15M | 0.02% | 961 |
|
|
2020
Q3 | $18.5M | Buy |
693,053
+44,395
| +7% | +$1.02M | 0.01% | 1252 |
|
|
2020
Q2 | $12.6M | Buy |
648,658
+96,722
| +18% | +$1.56M | 0.01% | 1492 |
|
|
2020
Q1 | $5.43M | Buy |
551,936
+38,888
| +8% | +$491K | ﹤0.01% | 1795 |
|
|
2019
Q4 | $5.7M | Buy |
513,048
+45,399
| +10% | +$345K | ﹤0.01% | 1956 |
|
|
2019
Q3 | $2.63M | Buy |
467,649
+31,216
| +7% | +$218K | ﹤0.01% | 2292 |
|
|
2019
Q2 | $3.78M | Buy |
436,433
+47,585
| +12% | +$360K | ﹤0.01% | 2110 |
|
|
2019
Q1 | $3.13M | Buy |
388,848
+40,634
| +12% | +$220K | ﹤0.01% | 2201 |
|
|
2018
Q4 | $1.43M | Buy |
348,214
+18,567
| +6% | +$92.3K | ﹤0.01% | 2430 |
|
|
2018
Q3 | $1.85M | Buy |
329,647
+15,895
| +5% | +$182K | ﹤0.01% | 2449 |
|
|
2018
Q2 | $4.13M | Buy |
313,752
+45,578
| +17% | +$627K | ﹤0.01% | 2101 |
|
|
2018
Q1 | $3.81M | Buy |
268,174
+1,204
| +0.5% | +$15.4K | ﹤0.01% | 2077 |
|
|
2017
Q4 | $2.19M | Buy |
266,970
+23,485
| +10% | +$205K | ﹤0.01% | 2274 |
|
|
2017
Q3 | $2.89M | Buy |
243,485
+155,535
| +177% | +$1.77M | ﹤0.01% | 2139 |
|
|
2017
Q2 | $884K | Buy |
87,950
+15,900
| +22% | +$178K | ﹤0.01% | 2498 |
|
|
2017
Q1 | $840K | Sell |
72,050
-26,200
| -27% | -$188K | ﹤0.01% | 2478 |
|
|
2016
Q4 | $457K | Buy |
98,250
+39,200
| +66% | +$230K | ﹤0.01% | 2689 |
|
|
2016
Q3 | $458K | Hold |
59,050
| – | – | ﹤0.01% | 2636 |
|
|
2016
Q2 | $358K | Hold |
59,050
| – | – | ﹤0.01% | 2715 |
|
|
2016
Q1 | $504K | Hold |
59,050
| – | – | ﹤0.01% | 2577 |
|
|
2015
Q4 | $705K | Hold |
59,050
| – | – | ﹤0.01% | 2502 |
|
|
2015
Q3 | $596K | Buy |
59,050
+9,300
| +19% | +$139K | ﹤0.01% | 2556 |
|
|
2015
Q2 | $826K | Buy |
49,750
+8,650
| +21% | +$137K | ﹤0.01% | 2504 |
|
|
2015
Q1 | $637K | Buy |
41,100
+6,700
| +19% | +$101K | ﹤0.01% | 2547 |
|
|
2014
Q4 | $545K | Hold |
34,400
| – | – | ﹤0.01% | 2590 |
|
|
2014
Q3 | $368K | Hold |
34,400
| – | – | ﹤0.01% | 2705 |
|
|
2014
Q2 | $324K | Sell |
34,400
-15,400
| -31% | -$98.5K | ﹤0.01% | 2824 |
|
|
2014
Q1 | $344K | Hold |
49,800
| – | – | ﹤0.01% | 2744 |
|
|
2013
Q4 | $195K | Buy |
49,800
+31,600
| +174% | +$128K | ﹤0.01% | 2959 |
|
|
2013
Q3 | $94K | Hold |
18,200
| – | – | ﹤0.01% | 3039 |
|
|
2013
Q2 | $121K | Buy |
+18,200
| New | +$117K | ﹤0.01% | 3009 |
|
Other funds holding TGTX
SCM
CAM
Charles Schwab's TGTX Position: Q2 2026 in Review
Charles Schwab increased its TG Therapeutics (TGTX) stake by 1.4% in Q2 2026, buying an estimated $739K and bringing the position to 1,313,103 shares worth $72.1M. The position accounts for 0.01% of the portfolio, ranked #990.
Charles Schwab first reported a position in TGTX in Q2 2013 and has held it in 53 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Charles Schwab held 1,313,103 shares of TG Therapeutics worth $72.1M as of Q2 2026.
- Charles Schwab bought 18,048 TG Therapeutics shares in Q2 2026, an estimated $739K.
- TG Therapeutics made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #990 holding.
- Charles Schwab first reported a position in TG Therapeutics in Q2 2013 and has held it in 53 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.